Connect with us

Uncategorized

Patients & Purpose: 2023

Patients & Purpose 200 Varick Street, 4th Floor, New York, NY 10014 etyler@patientsandpurpose.com • patientsandpurpose.com Quick Facts Accounts Account…

Published

on

Patients & Purpose

200 Varick Street, 4th Floor, New York, NY 10014

etyler@patientsandpurpose.compatientsandpurpose.com

Quick Facts

Accounts

  • Account wins: 5
  • Active business clients: 13

Brands by 2022 sales

  • Brand-product accounts held: 24

Services mix

  • DTC/DTP: 50%
  • Consumer interactive: 30%
  • Social/influencer: 20%

Client roster

  • AstraZeneca
  • Bausch+Lomb
  • Biogen
  • BioMarin Pharmaceutical
  • Corcept Therapeutics
  • Eisai
  • Novavax
  • Novocure
  • Otsuka Pharmaceutical
  • Pfizer
  • Provention Bio
  • Takeda
  • Vertex Pharmaceuticals

Patients & Purpose (P&P) is the health marketing industry’s premier patient agency, according to leaders. “For 20-plus years across 150-plus brands, P&P has been transforming the patient experience through digital innovation, data mastery, unparalleled insights, and breakthrough creative,” executives say. “It’s an agency that lives up to its mantra: no one knows patients better.” 

Leaders say P&P saw double-digit growth in 2022 and is poised to match that by “doubling down on its patient-centric, future-focused vision.”

“One of the things that’s made us an industry leader all these years is our commitment to evolving how we work, how we partner with clients, and most importantly, how we engage patients,” says Deb Deaver, CEO of P&P. 

Recent accomplishments

(left to right) Eliot Tyler, president; Deb Deaver, CEO; Dina Peck, chief creative officer

The agency launched a wide range of brands and programs in 2022, from breakthrough DTC campaigns to best-in-class patient support, leaders say. 

P&P President Eliot Tyler states that he’s proud of the agency’s diversification across therapeutic areas and clients. “Not only is it healthy for our business, but it also broadens our experience,” Tyler says. “And we’re able to draw on that to better serve brands and their patients.” 

Social marketing was a bigger part of P&P budgets in 2022, according to the leadership team, adding that 80 percent of the agency’s brands are deeply engaged in social. 

“Many of our brands are continuing to broaden their social horizons on platforms like TikTok, where authenticity is critical,” says  John Deely, director of digital experience. “Our end-to-end social center of excellence works with patients, influencers, and other creators to make sure brand experiences are authentic.”

Leaders maintain that historically, P&P has earned some professional work from brands impressed because of the agency’s work on the patient side. Because of growing demand in recent years, P&P launched a sister agency, Science & Purpose, with a particular focus on integrated HCP and patient marketing.

“Science has never been more relevant or transformative,” Deaver says. “By amplifying the science of data, behavior, language, and design, and bridging the gaps that exist in healthcare, we can have a greater impact on HCPs and patients. She adds that the launch of Science & Purpose also led to the newly formed Purpose Group that will continue to expand for client needs.

Structure and services

Leaders describe P&P as a  full-service agency that has a broad range of patient experience and expertise across brand building, creative, digital, and data. Executives say the awgency works on brands of all types and sizes, from pre-launch to post-LOE, rare to common, and DTP to DTC. The agency also has global partners across every area of health, as part of Omnicom Health Group. 

The agency’s offerings include centers of excellence (COEs) that executives state truly live up to the title. “Our specialized COEs get to the heart of patient needs,” Tyler says. “By pinpointing those needs, we’re able to bring in just the right expertise, when and how brands need it.”

Through the agency’s Emerging Digital Group (called “Edge”), leaders say P&P helps clients embrace the latest trends to create more engaging and impactful patient work. “There’s a lot to be excited about,” Deely says. “Web 3, the metaverse, virtual humans, and next-level AI tools, like ChatGPT… But our focus is on purposeful innovation. It always comes back to a patient-first approach that can create the most value for brands.”

Much of the agency’s work is in the digital space, so the leadership team believes experience design is a key discipline. Beyond best practices and design trends, accessibility has been central to the agency’s approach, which it calls Healthy Communications and Healthy Design. 

According to Dina Peck, chief creative officer, “Especially in healthcare, we need to be mindful of the needs and limitations of patients and those that love them. With a consistently expanding health literacy offering that includes language, accessibility, and more, we can turn barriers to engagement into drivers of it.”

P&P executives believe that patient services programs can be a difference maker for adherence and outcomes, and a differentiator for clients and brands. “With our Patient Services Experience team, we’ve created many of today’s best-in-class programs,” says Dana LaPiana, director of client services. “It all starts with looking at the bigger patient picture, which helps us take a more holistic approach to driving treatment success.”

According to managers, with its Equal Health Group, the agency pulls DE&I principles through to brand work, to help close the gap for underserved patients. “It’s important to understand each patient community’s unique cultural codes, lexicon, and habits,” Peck says. “Straight translations do brands a disservice, because they don’t properly account for cultural nuances. That’s a big reason why we advocate for cultural adaptation.”

Future plans

Novavax, Patients & Purpose

P&P used a dynamic split-screen campaign to build awareness of Novavax and show their commitment to protecting people from some of the world’s most challenging infectious diseases—so that families and everyday people can focus on what matters most.

To P&P, meeting patients where they are isn’t going far enough. Leadership says a key goal for 2023 is to help more brands meet patients where they’re going – with data-driven, omnichannel experiences. “With our Emerging Digital Group, we can deliver the personalization and integration that patients have come to expect,” Deely says. “The key with omnichannel is to build toward it and make impactful improvements to your brand experience along the way.” 

DTC is another area where P&P will be helping brands stretch, according to leaders, adding that the agency has been redefining the broadcast model to help clients’ budgets go further by using connected TV, web TV, and even social,

P&P managers state that the agency has long seen social as a core marketing channel for patients, and in 2023, will be pushing brands to get more out of it. By leaning into partnerships with influencers and creators, the agency believes it can help brands extend reach, enrich content strategy, build credibility, and more deeply connect with patients. And with its lo-fi creator studio, P&P can meet the content demands of social feeds with authentic, efficient production.

The leadership team says it recognizes that timelines are increasingly crunched and the bar for breakthrough creative continues to be raised,  so P&P is responding by rolling out new processes for creative sprints and holistic ideation.

Philanthropy/citizenship

According to agency leaders, P&P takes its mission to heart so much that every employee gets a paid service day off each year, called a “Purpose Day.” They add that the agency is just as committed to DE&I and embedding it in culture. Executives say from talent sourcing to employee training, P&P has many initiatives designed to create a more diverse and inclusive workplace. 

In terms of pro bono work, P&P is particularly proud of its partnership with the New York City Parks Foundation, leaders maintain. “Something many of us experienced firsthand was the impact the pandemic had on mental health,” Peck says. “And with our Nature Heals campaign, we were able to open New Yorkers’ minds to a simple solution, right in their own backyard: city parks.”

Read More

Continue Reading

Uncategorized

Aging at AACR Annual Meeting 2024

BUFFALO, NY- March 11, 2024 – Impact Journals publishes scholarly journals in the biomedical sciences with a focus on all areas of cancer and aging…

Published

on

BUFFALO, NY- March 11, 2024 – Impact Journals publishes scholarly journals in the biomedical sciences with a focus on all areas of cancer and aging research. Aging is one of the most prominent journals published by Impact Journals

Credit: Impact Journals

BUFFALO, NY- March 11, 2024 – Impact Journals publishes scholarly journals in the biomedical sciences with a focus on all areas of cancer and aging research. Aging is one of the most prominent journals published by Impact Journals

Impact Journals will be participating as an exhibitor at the American Association for Cancer Research (AACR) Annual Meeting 2024 from April 5-10 at the San Diego Convention Center in San Diego, California. This year, the AACR meeting theme is “Inspiring Science • Fueling Progress • Revolutionizing Care.”

Visit booth #4159 at the AACR Annual Meeting 2024 to connect with members of the Aging team.

About Aging-US:

Aging publishes research papers in all fields of aging research including but not limited, aging from yeast to mammals, cellular senescence, age-related diseases such as cancer and Alzheimer’s diseases and their prevention and treatment, anti-aging strategies and drug development and especially the role of signal transduction pathways such as mTOR in aging and potential approaches to modulate these signaling pathways to extend lifespan. The journal aims to promote treatment of age-related diseases by slowing down aging, validation of anti-aging drugs by treating age-related diseases, prevention of cancer by inhibiting aging. Cancer and COVID-19 are age-related diseases.

Aging is indexed and archived by PubMed/Medline (abbreviated as “Aging (Albany NY)”), PubMed CentralWeb of Science: Science Citation Index Expanded (abbreviated as “Aging‐US” and listed in the Cell Biology and Geriatrics & Gerontology categories), Scopus (abbreviated as “Aging” and listed in the Cell Biology and Aging categories), Biological Abstracts, BIOSIS Previews, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

Please visit our website at www.Aging-US.com​​ and connect with us:

  • Aging X
  • Aging Facebook
  • Aging Instagram
  • Aging YouTube
  • Aging LinkedIn
  • Aging SoundCloud
  • Aging Pinterest
  • Aging Reddit

Click here to subscribe to Aging publication updates.

For media inquiries, please contact media@impactjournals.com.


Read More

Continue Reading

Uncategorized

NY Fed Finds Medium, Long-Term Inflation Expectations Jump Amid Surge In Stock Market Optimism

NY Fed Finds Medium, Long-Term Inflation Expectations Jump Amid Surge In Stock Market Optimism

One month after the inflation outlook tracked…

Published

on

NY Fed Finds Medium, Long-Term Inflation Expectations Jump Amid Surge In Stock Market Optimism

One month after the inflation outlook tracked by the NY Fed Consumer Survey extended their late 2023 slide, with 3Y inflation expectations in January sliding to a record low 2.4% (from 2.6% in December), even as 1 and 5Y inflation forecasts remained flat, moments ago the NY Fed reported that in February there was a sharp rebound in longer-term inflation expectations, rising to 2.7% from 2.4% at the three-year ahead horizon, and jumping to 2.9% from 2.5% at the five-year ahead horizon, while the 1Y inflation outlook was flat for the 3rd month in a row, stuck at 3.0%. 

The increases in both the three-year ahead and five-year ahead measures were most pronounced for respondents with at most high school degrees (in other words, the "really smart folks" are expecting deflation soon). The survey’s measure of disagreement across respondents (the difference between the 75th and 25th percentile of inflation expectations) decreased at all horizons, while the median inflation uncertainty—or the uncertainty expressed regarding future inflation outcomes—declined at the one- and three-year ahead horizons and remained unchanged at the five-year ahead horizon.

Going down the survey, we find that the median year-ahead expected price changes increased by 0.1 percentage point to 4.3% for gas; decreased by 1.8 percentage points to 6.8% for the cost of medical care (its lowest reading since September 2020); decreased by 0.1 percentage point to 5.8% for the cost of a college education; and surprisingly decreased by 0.3 percentage point for rent to 6.1% (its lowest reading since December 2020), and remained flat for food at 4.9%.

We find the rent expectations surprising because it is happening just asking rents are rising across the country.

At the same time as consumers erroneously saw sharply lower rents, median home price growth expectations remained unchanged for the fifth consecutive month at 3.0%.

Turning to the labor market, the survey found that the average perceived likelihood of voluntary and involuntary job separations increased, while the perceived likelihood of finding a job (in the event of a job loss) declined. "The mean probability of leaving one’s job voluntarily in the next 12 months also increased, by 1.8 percentage points to 19.5%."

Mean unemployment expectations - or the mean probability that the U.S. unemployment rate will be higher one year from now - decreased by 1.1 percentage points to 36.1%, the lowest reading since February 2022. Additionally, the median one-year-ahead expected earnings growth was unchanged at 2.8%, remaining slightly below its 12-month trailing average of 2.9%.

Turning to household finance, we find the following:

  • The median expected growth in household income remained unchanged at 3.1%. The series has been moving within a narrow range of 2.9% to 3.3% since January 2023, and remains above the February 2020 pre-pandemic level of 2.7%.
  • Median household spending growth expectations increased by 0.2 percentage point to 5.2%. The increase was driven by respondents with a high school degree or less.
  • Median year-ahead expected growth in government debt increased to 9.3% from 8.9%.
  • The mean perceived probability that the average interest rate on saving accounts will be higher in 12 months increased by 0.6 percentage point to 26.1%, remaining below its 12-month trailing average of 30%.
  • Perceptions about households’ current financial situations deteriorated somewhat with fewer respondents reporting being better off than a year ago. Year-ahead expectations also deteriorated marginally with a smaller share of respondents expecting to be better off and a slightly larger share of respondents expecting to be worse off a year from now.
  • The mean perceived probability that U.S. stock prices will be higher 12 months from now increased by 1.4 percentage point to 38.9%.
  • At the same time, perceptions and expectations about credit access turned less optimistic: "Perceptions of credit access compared to a year ago deteriorated with a larger share of respondents reporting tighter conditions and a smaller share reporting looser conditions compared to a year ago."

Also, a smaller percentage of consumers, 11.45% vs 12.14% in prior month, expect to not be able to make minimum debt payment over the next three months

Last, and perhaps most humorous, is the now traditional cognitive dissonance one observes with these polls, because at a time when long-term inflation expectations jumped, which clearly suggests that financial conditions will need to be tightened, the number of respondents expecting higher stock prices one year from today jumped to the highest since November 2021... which incidentally is just when the market topped out during the last cycle before suffering a painful bear market.

Tyler Durden Mon, 03/11/2024 - 12:40

Read More

Continue Reading

Uncategorized

Homes listed for sale in early June sell for $7,700 more

New Zillow research suggests the spring home shopping season may see a second wave this summer if mortgage rates fall
The post Homes listed for sale in…

Published

on

  • A Zillow analysis of 2023 home sales finds homes listed in the first two weeks of June sold for 2.3% more. 
  • The best time to list a home for sale is a month later than it was in 2019, likely driven by mortgage rates.
  • The best time to list can be as early as the second half of February in San Francisco, and as late as the first half of July in New York and Philadelphia. 

Spring home sellers looking to maximize their sale price may want to wait it out and list their home for sale in the first half of June. A new Zillow® analysis of 2023 sales found that homes listed in the first two weeks of June sold for 2.3% more, a $7,700 boost on a typical U.S. home.  

The best time to list consistently had been early May in the years leading up to the pandemic. The shift to June suggests mortgage rates are strongly influencing demand on top of the usual seasonality that brings buyers to the market in the spring. This home-shopping season is poised to follow a similar pattern as that in 2023, with the potential for a second wave if the Federal Reserve lowers interest rates midyear or later. 

The 2.3% sale price premium registered last June followed the first spring in more than 15 years with mortgage rates over 6% on a 30-year fixed-rate loan. The high rates put home buyers on the back foot, and as rates continued upward through May, they were still reassessing and less likely to bid boldly. In June, however, rates pulled back a little from 6.79% to 6.67%, which likely presented an opportunity for determined buyers heading into summer. More buyers understood their market position and could afford to transact, boosting competition and sale prices.

The old logic was that sellers could earn a premium by listing in late spring, when search activity hit its peak. Now, with persistently low inventory, mortgage rate fluctuations make their own seasonality. First-time home buyers who are on the edge of qualifying for a home loan may dip in and out of the market, depending on what’s happening with rates. It is almost certain the Federal Reserve will push back any interest-rate cuts to mid-2024 at the earliest. If mortgage rates follow, that could bring another surge of buyers later this year.

Mortgage rates have been impacting affordability and sale prices since they began rising rapidly two years ago. In 2022, sellers nationwide saw the highest sale premium when they listed their home in late March, right before rates barreled past 5% and continued climbing. 

Zillow’s research finds the best time to list can vary widely by metropolitan area. In 2023, it was as early as the second half of February in San Francisco, and as late as the first half of July in New York. Thirty of the top 35 largest metro areas saw for-sale listings command the highest sale prices between May and early July last year. 

Zillow also found a wide range in the sale price premiums associated with homes listed during those peak periods. At the hottest time of the year in San Jose, homes sold for 5.5% more, a $88,000 boost on a typical home. Meanwhile, homes in San Antonio sold for 1.9% more during that same time period.  

 

Metropolitan Area Best Time to List Price Premium Dollar Boost
United States First half of June 2.3% $7,700
New York, NY First half of July 2.4% $15,500
Los Angeles, CA First half of May 4.1% $39,300
Chicago, IL First half of June 2.8% $8,800
Dallas, TX First half of June 2.5% $9,200
Houston, TX Second half of April 2.0% $6,200
Washington, DC Second half of June 2.2% $12,700
Philadelphia, PA First half of July 2.4% $8,200
Miami, FL First half of June 2.3% $12,900
Atlanta, GA Second half of June 2.3% $8,700
Boston, MA Second half of May 3.5% $23,600
Phoenix, AZ First half of June 3.2% $14,700
San Francisco, CA Second half of February 4.2% $50,300
Riverside, CA First half of May 2.7% $15,600
Detroit, MI First half of July 3.3% $7,900
Seattle, WA First half of June 4.3% $31,500
Minneapolis, MN Second half of May 3.7% $13,400
San Diego, CA Second half of April 3.1% $29,600
Tampa, FL Second half of June 2.1% $8,000
Denver, CO Second half of May 2.9% $16,900
Baltimore, MD First half of July 2.2% $8,200
St. Louis, MO First half of June 2.9% $7,000
Orlando, FL First half of June 2.2% $8,700
Charlotte, NC Second half of May 3.0% $11,000
San Antonio, TX First half of June 1.9% $5,400
Portland, OR Second half of April 2.6% $14,300
Sacramento, CA First half of June 3.2% $17,900
Pittsburgh, PA Second half of June 2.3% $4,700
Cincinnati, OH Second half of April 2.7% $7,500
Austin, TX Second half of May 2.8% $12,600
Las Vegas, NV First half of June 3.4% $14,600
Kansas City, MO Second half of May 2.5% $7,300
Columbus, OH Second half of June 3.3% $10,400
Indianapolis, IN First half of July 3.0% $8,100
Cleveland, OH First half of July  3.4% $7,400
San Jose, CA First half of June 5.5% $88,400

 

The post Homes listed for sale in early June sell for $7,700 more appeared first on Zillow Research.

Read More

Continue Reading

Trending